Skip to main content

Want a detailed portfolio tracker?

Sol-Gel Technologies (SLGL) P/E (2018 - 2026)

Sol-Gel Technologies (SLGL) P/E from Feb 1, 2018 to Jul 21, 2026. The TTM Sol-Gel Technologies (SLGL) P/E is -40.78. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Sol-Gel Technologies (SLGL)

YearP/EChange
2026-40.78+112.96%
2025-19.15+681.87%
2024-2.45+42.99%
2023-1.71-105.23%
202232.75-38.38%
202153.15-791.33%
2020-7.69-43.53%
2019-13.61+1034.92%
2018-1.20N/A

Comparison Sol-Gel Technologies (SLGL) P/E with competitors

Sol-Gel Technologies (SLGL) P/E is -40.78.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.00%
NBYStablecoin Development Corp0.00-100.01%
ENLVEnlivex Ltd0.07-100.18%
FGENFibroGen Inc0.24-100.59%
CHRSCoherus Biosciences Inc0.85-102.08%
FBIOFortress Biotech Inc0.95-102.33%
ORMPOramed Pharmaceuticals Inc1.50-103.69%
AGENAgenus Inc3.01-107.38%
INVAInnoviva Inc3.15-107.73%
VXRTVaxart Inc3.55-108.70%
CRMDCorMedix Inc3.63-108.90%
CVACCureVac N.V.4.45-110.90%
GLPGGalapagos NV4.86-111.91%
SRPTSarepta Therapeutics Inc4.88-111.97%
ABEOAbeona Therapeutics Inc5.39-113.21%
ABUSArbutus Biopharma Corp5.60-113.72%
ZVRAZevra Therapeutics Inc5.89-114.44%
SPROSpero Therapeutics Inc6.23-115.27%
CGENCompugen Ltd6.31-115.48%
RIGLRigel Pharmaceuticals6.87-116.85%
SLXNSilexion Therapeutics Corp7.30-117.89%
OMEROmeros Corporation9.26-122.70%
AUPHAurinia Pharmaceuticals Inc9.58-123.50%
PLXProtalix BioTherapeutics Inc10.89-126.70%
ACADAcadia Pharmaceuticals Inc11.73-128.76%
TBPHTheravance Biopharma Inc12.26-130.07%
ADMAAdma Biologics Inc12.42-130.45%
HRMYHarmony Biosciences Holdings Inc13.82-133.89%
SABSSAB Biotherapeutics Inc14.14-134.66%
NAGENiagen Bioscience Inc14.82-136.33%
INCYIncyte Corp15.82-138.80%
REGNRegeneron Pharmaceuticals Inc15.86-138.88%
PBYIPuma Biotechnology Inc17.32-142.46%
CPRXCatalyst Pharmaceuticals Inc17.44-142.76%
EXELExelixis Inc17.54-143.00%
TGTXTG Therapeutics Inc18.97-146.50%
MDXGMimedx Group Inc20.55-150.39%
XOMAXOMA Royalty Corp22.87-156.09%
ARGXArgen X SE24.30-159.58%
CTMXCytomX Therapeutics Inc24.82-160.86%
XOMAOXOMA Royalty Corp25.34-162.15%
HALOHalozyme Therapeutics Inc25.62-162.83%
XOMAPXOMA Royalty Corp25.67-162.94%
VRTXVertex Pharmaceuticals Inc27.99-168.64%
RPRXRoyalty Pharma plc - Class A28.69-170.34%
SLNOSoleno Therapeutics Inc29.02-171.15%
ASNDAscendis Pharma A/S30.09-173.77%
LGNDLigand Pharmaceuticals Inc - Class B37.91-192.96%
APLSApellis Pharmaceuticals Inc39.02-195.68%
BMRNBiomarin Pharmaceutical Inc42.21-203.50%
KRYSKrystal Biotech Inc45.34-211.18%
ONCBeiGene Ltd69.54-270.51%
PHARPharming Group N.V.75.03-283.96%
TECHBio-Techne Corp101.96-350.00%
VCELVericel Corp109.92-369.53%
ALNYAlnylam Pharmaceuticals Inc117.96-389.25%
GMABGenmab140.29-444.00%
TLXTelix Pharmaceuticals Ltd162.15-497.60%
CORTCorcept Therapeutics Inc212.86-621.93%